Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

180.62
-1.1800-0.65%
Post-market: 180.620.00000.00%19:27 EDT
Volume:1.08M
Turnover:194.81M
Market Cap:11.12B
PE:-30.93
High:184.00
Open:181.93
Low:179.16
Close:181.80
52wk High:198.00
52wk Low:95.49
Shares:61.56M
Float Shares:58.65M
Volume Ratio:1.54
T/O Rate:1.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8403
EPS(LYR):-5.8403
ROE:-8.47%
ROA:5.22%
PB:2.57
PE(LYR):-30.93

Loading ...

ALX Oncology Reports CD47 Biomarker Predicts Response to Evorpacept in Advanced HER2-Positive Breast Cancer

Reuters
·
Jan 30

Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA), Nurix Therapeutics (NRIX) and Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
Jan 29

Jazz Pharmaceuticals Plc : TD Cowen Raises Target Price to $220 From $205

THOMSON REUTERS
·
Jan 29

Analysts Have Conflicting Sentiments on These Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and AbbVie (ABBV)

TIPRANKS
·
Jan 16

Analysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA), Jazz Pharmaceuticals (JAZZ) and Annexon Biosciences (ANNX)

TIPRANKS
·
Jan 16

Jazz Pharmaceuticals Showcases Rare Disease Breakthroughs and Growth Strategy in New Presentation

Reuters
·
Jan 14

Jazz Pharmaceuticals (JAZZ) Gets a Buy from Jefferies

TIPRANKS
·
Jan 13

BRIEF-Jazz Pharmaceuticals PLC - Expects To Meet 2025 Revenue Guidance - SEC Filing

Reuters
·
Jan 12

Jazz Pharmaceuticals Plc - Expects to Meet 2025 Revenue Guidance - SEC Filing

THOMSON REUTERS
·
Jan 12

Jazz Pharmaceuticals Completes Acquisition of Chimerix

Reuters
·
Jan 12

Jazz Pharmaceuticals price target raised to $235 from $210 at Needham

TIPRANKS
·
Jan 12

Truist Raises Price Target on Jazz Pharmaceuticals to $230 From $220, Keeps Buy Rating

MT Newswires Live
·
Jan 12

Boehringer Ingelheim: Phase 1B Study to Evaluate Combination of Zongertinib and Zanidatamab in Her2-Positive Breast Cancer Patients

THOMSON REUTERS
·
Jan 12

Jazz Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Jan 12

U.S. RESEARCH ROUNDUP-American Express, Ameriprise Financial, Mastercard

Reuters
·
Jan 12

Jazz Pharmaceuticals Plc : Needham Raises Target Price to $235 From $210

THOMSON REUTERS
·
Jan 12

Jazz Pharmaceuticals Plc : Truist Securities Raises Target Price to $230 From $220

THOMSON REUTERS
·
Jan 12

Is Jazz Pharmaceuticals (JAZZ) Still Attractive After 33% Share Price Gain This Year?

Simply Wall St.
·
Jan 11

Jazz Pharmaceuticals Names Chief Business Officer

MT Newswires Live
·
Jan 09

Press Release: Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer

Dow Jones
·
Jan 09